Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
Jean-François Bosset(Université de Franche-Comté), Laurence Collette(GlaxoSmithKline (Belgium)), É. Bardet(Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers), Dominique Marchal(Grand Charleroi Hospital), J. Giralt(Vall d'Hebron Hospital Universitari), Jean‐Luc Van Laethem(Deventer Ziekenhuis), René‐Jean Bensadoun(Centre Hospitalier Universitaire de Poitiers), Vincent Klein(Centre National de la Recherche Scientifique), Laurent Mineur(Institut Sainte Catherine), M. Bolla(Centre Hospitalier Universitaire de Grenoble), P. Clavère(Centre Hospitalier Universitaire de Limoges), Suzana Stojanović-Rundić(University of Belgrade), Alexander Beny(Rambam Health Care Campus), P. Maingon(Sorbonne Université), Jean-Claude Ollier(Institut de Cancérologie Strasbourg), P. Cellier(Institut de Cancérologie de l'Ouest), Christoph Glanzmann(Luzerner Kantonsspital), G. Calais(Centre Hospitalier Universitaire de Tours)
Cited by 727
Related Papers
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
|The Lancet|2002|1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k